Verteporfin

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Ranibizumab and Reduced Fluence PDT for AMD

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration

Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies

An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer

Treatment of Primary Breast Cancer Using PDT

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy

Lucentis KAV Study

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)